This activity is supported by educational grants from Sanofi US, Novo Nordisk, Inc and Merck Sharp & Dohme Corp.
Convenient Healthcare and Pharmacy Collaborative On-demand Webcast
Achieving Glycemic Control: Promoting Patient Self-Monitoring and Exploring Innovative Treatment Strategies in the Convenient Care Setting
Dhiren Patel, PharmD, CDE, BC-ADM, BCACP
Associate Professor of Pharmacy Practice
MCPHS University, Boston, MA
Clinical Pharmacy Specialist – Endocrine Clinic
VA Boston Healthcare System
This webcast was video-taped during the live session at the 2nd Annual Convenient Healthcare and Pharmacy Collaborative conference and is now available for viewing on-demand. Please note that if you attended the live session on July 20, 2016, you cannot request credit for this enduring version.
At the completion of this activity, the participant will be able to:
Jointly provided by Dannemiller and Pharmacy Times Continuing Education.
Examine the relationship between patient self-monitoring of blood glucose levels and patient outcomes in type 2 diabetes
Explain monotherapy and combination strategies utilizing DPP-4 inhibitors, SGLT-2 inhibitors, and GLP-1 agonists
Apply short- and long-acting GLP-1 agonists effectively in managing type 2 diabetes
Illustrate patient education, counseling tools, and resources to improve patient outcomes
Pharmacy Times Continuing Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity number 0290-9999-16-129-H01-P The activity is available for CE credit through September 23, 2017.
Pharmacists, Nurse Practitioners, Physician Assistants
Type of Activity:
Length of Webinar:
September 23, 2016
September 23, 2017
This activity is offered to pharmacists free of charge at www.pharmacytimes.org.
Instructions for Completing the Activity and Receiving CPE Credit
To receive a CPE credit, participants must complete the pre-test, view the webinar in its entirety, complete the post-test with a score of 70% or better before the activity expires, and complete the online activity evaluation. After successful completion of the online posttest and activity evaluation, your credit will be uploaded to CPE MonitorTM
. You may view your credit within 48 hours at www.mycpemonitor.net
All steps must be completed in order to receive credit. Please ensure your Pharmacy Times account is updated with your NABP e-profile number and your date of birth. Participation data will not be uploaded into CPE MonitorTM
if you do not have your NABP e-profile number and date of birth entered into your profile on www.pharmacytimes.org
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Dannemiller and Pharmacy Times Continuing Education. Dannemiller is accredited by the ACCME to provide continuing medical education for physicians.
Dannemiller designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit(s)TM
from organizations accredited by ACCME.
Dannemiller is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 090419.
This program is accredited for 1.0 contact hour(s) which includes 1.0 hours of pharmacology.
How to Obtain CME and AANP Credit:
To receive credit, participants must complete the pretest, view the webcast in its entirety and complete the online evaluation and posttest with a score of 70% or better before the activity expires. After successful completion and submission of the online posttest and activity evaluation you can request credit.
Dhiren Patel, PharmD, CDE, BC-ADM, BCACP,
has the following relevant financial relationships with commercial interests to disclose.
Speaker’s Bureau: Novo Nordisk, Merck, Sanofi
Advisory Board: Novo Nordisk, Astra Zeneca, Sanofi
Consultant: Astra Zeneca, Novo Nordisk, Sanofi
The following contributors have no relevant financial relationships with commercial interests to disclose.
– Gordon Ringler; Jennifer Hodge
Pharmacy Times Continuing Education
– David Heckard; Maryjo Dixon, RPh; Dipti Desai, PharmD, RPh; Donna Fausak; and Tara DeLorenzo.
An anonymous peer reviewer is used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.
Required: Windows® 7, Vista, XP, 2003 Server or 2000
Required: Mac OS® X 10.4.11 (Tiger®) or newer
For questions about this Internet CPE activity, please contact: firstname.lastname@example.org